Prevalence of Neisseria meningitidis carriers in children under five years of age and teenagers in certain populations of Mexico city;Prevalencia de portadores de Neisseria meningitidis en niños menores de cinco años de edad y adolescents en determinadas poblaciones de la ciudad de México

Salud Publica de Mexico

Volumn 51, Issue 2, 2009, Pages 114-118

  Espinosa de los Monteros, Luz Elena ^a   Aguilar Ituarte, Felipe ^b   Jiménez Rojas, Leticia Verónica ^b   Kuri, Pablo ^c   Rodríguez Suárez, Romeo S ^c   Gómez Barreto, Demóstenes ^a  

^a Manuel Gea González   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c SECRETARÍA DE SALUD   (Mexico)

Author keywords

Nasopharynx; Neisseria meningitidis; Serogroup

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLASSIFICATION; CROSS-SECTIONAL STUDY; DAY CARE; EPIDEMIC MENINGITIS; HETEROZYGOTE; HUMAN; INFANT; ISOLATION AND PURIFICATION; MEXICO; MICROBIOLOGY; NASOPHARYNX; NEISSERIA MENINGITIDIS; PILOT STUDY; PRESCHOOL CHILD; PREVALENCE; RESIDENTIAL HOME; SEROTYPING; STATISTICS; UNIVERSITY; URBAN POPULATION;

ADOLESCENT; CARRIER STATE; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; HUMANS; INFANT; MENINGITIS, MENINGOCOCCAL; MEXICO; NASOPHARYNX; NEISSERIA MENINGITIDIS; PILOT PROJECTS; PREVALENCE; RESIDENTIAL FACILITIES; SEROTYPING; UNIVERSITIES; URBAN POPULATION; YOUNG ADULT;

EID: 67650156883     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/S0036-36342009000200006     Document Type: Article

References (28)

1. Soult Rubio JA, Muñoz Sáez M. Invasive meningococcal disease. An Pediatr (Barc). 2005;62(4):297-303.
2. World Health Organization. Control of Epidemics Meningococcal Disease: Who practical Guidelines, 2nd ed. Geneva: WHO, 1998. [Available at: http:/www.who.int/emc]
3. Cartwright KA, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987;99(3):591-601.
4. Caugant DA, Høiby EA, Magnus P, Scheel O, Hoel T, Bjune G, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 1994;32(2):323-330.
5. Tikhomirov E, Santamaria M, Esteves K. Meningococcal disease: public health burden and control. World Health Stat Q 1997;50(3-4):170-177.
6. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001;344(18):1378-1388.
7. Brooks RB, Woods CW. Neisseria meningitidis outbreaks in the United States 1994-2002. In: Abstracts of the 41st Annual Meeting of the Infectious Diseases Society of America, San Diego, California. October 9-11, 2004:81-2
8. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA 1995; 273(5):383-389.
9. Faber J, Schuessler T, Finn A, Murdoch C, Zenz W, Habermehl P, et al. Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood. Pediatr Infect Dis J 2007;26(3):243-246.
10. Einhorn MS, Weinberg GA, Anderson EL, Granoff PD, Granoff DM. Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein. Lancet 1986;2(8502):299-302.
11. Exley RM, Goodwin L, Mowe E, Shaw J, Smith H, Read RC, et al. Neisseria meningitidis lactate permease is required for nasopharyngeal colonization. Infect Immun 2005;73(9):5762-5766.
12. Siamak PY, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, Musilek M, et al. Distribution of Serogroups and Genotypes among Disease-Associated and Carried Isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 2004;42(11):5146-5153.
13. Frasch CE, Zollinger WD, Poolman JT. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 1985;7(4):504-510.
14. Kirsch EA, Barton RP, Kitchen L, Giroir BP. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J 1996;15(11):967-978.
15. Pollard AJ, Levin M. Vaccines for prevention of meningococcal disease. Pediatr Infect Dis J 2000;19(4):333-344.
16. Balmer P, Miller E. Meningococcal disease: how to prevent and how to manage. Curr Opin Infect Dis 2002;15(3):275-281.
17. Bilukha O, Rosenstein N. National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005 May 27;54(RR-7):1-21.
18. Van Deuren M, Brandtzaeg P, van der Meer JW. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000;13(1):144-166.
19. Jolley KA, Kalmusova J, Feil EJ, Gupta S, Musilek M, Kriz P, et al. Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol 2000;38(12):4492-4498.
20. Sparling PF. A plethora of host factors that determine the outcome of meningococcal infection. Am J Med 2002;112(1):72-74
21. Sistema Nacional de Vigilancia Epidemiologica. Anuarios de Morbilidad de la Direccion General de Epidemiologia 2000-2004 (Morbility yearbook from the Epidemiology General Management 2000- 2004). Available at: http/www.dgepi.org.mx
22. Janda WM, Knapp JS. Neisseriaceae. In: Manual of Clinical Microbiology Ed. Murray P, Baro E, Jorgensen J, Pfaller M y Yolken R. 8th Ed. Washington DC: American Society for Microbiology, 2003:585.
23. Popovic T, Ajello G, Facklam R. Laboratory Methods for the diagnosis of meningitis caused by Neisseria menigitidis, Streptococcus penumoniae and Haemophilus influenzae. Manual. Geneva: WHO, 1998.
24. Wedge E, Hoiby E, Rosenqvist E, Froholm L. Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J Med Microbiol 1990;31:195-201
25. Ala'Aldeen DA, Neal KR, Ait-Tahar K, Nguyen-Van-Tam JS, English A, Falla TJ, et al. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 2000;38(6):2311-2316.
26. Active Bacterial Core Surveillance (ABCs) (1997-2002) Meningococcal surveillance reports. Available at: www.cdc.gov.ncidod/abcs/ [consulted July 15, 2004]
27. Yazdankhah SP, Caugant DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol 2004;53(Pt 9):821-832.
28. Kellerman SE, McCombs K, Ray M, Baughman W, Reeves MW, Popovic T, et al. Georgia Emerging Infections Program. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper-and hyposporadic rates of meningococcal disease. J Infect Dis 2002;186(1): 40-48.